Of these, the most consistent association in the literature has been depletion of Faecalibacterium prausnitzii, which has been shown to reduce severity of experimental colitis through production of anti-inflammatory products such as butyrate and a novel protein, MAM [83, 84]. The gene discussed is SGCG; the disease is colitis.